TSS
CDIO icon

Two Sigma Securities’s Cardio Diagnostics CDIO Stock Holding History

Two Sigma Securities’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,408
Closed -$13.9K – 1558
2025
Q1 		$13.9K Sell
1,408
-348
-20% -$5.42K ﹤0.01% 1167
2024
Q4 		$48.3K Buy
+1,756
New +$24.3K 0.01% 1189
2024
Q3 		– Sell
-1,914
Closed -$31.6K – 2943
2024
Q2 		$31.6K Buy
1,914
+1,350
+239% +$31.8K ﹤0.01% 2633
2024
Q1 		$24K Buy
+564
New +$32.1K ﹤0.01% 2656
2023
Q4 		– Sell
-1,075
Closed -$11K – 3067
2023
Q3 		$11K Buy
+1,075
New +$25.8K ﹤0.01% 2681

Other funds holding CDIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Securities's CDIO Position: Q2 2025 in Review

Two Sigma Securities sold out of Cardio Diagnostics (CDIO) in Q2 2025, closing a stake of 1,408 shares — an estimated $13.9K sold.

Two Sigma Securities first reported a position in CDIO in Q3 2023 and held it in 5 quarters. The position peaked at $48.3K in Q4 2024. 16 funds tracked by Wall St. Rank hold CDIO as of Q2 2025.

  • Two Sigma Securities reported no remaining Cardio Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,408 Cardio Diagnostics shares in Q2 2025, an estimated $13.9K.
  • Two Sigma Securities first reported a position in Cardio Diagnostics in Q3 2023 and held it in 5 quarters.
  • Two Sigma Securities's Cardio Diagnostics position peaked at $48.3K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.